Masaki Ichikawa

938 total citations
25 papers, 756 citations indexed

About

Masaki Ichikawa is a scholar working on Ophthalmology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Masaki Ichikawa has authored 25 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 8 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Masaki Ichikawa's work include Glaucoma and retinal disorders (9 papers), Retinal Development and Disorders (6 papers) and Nitric Oxide and Endothelin Effects (3 papers). Masaki Ichikawa is often cited by papers focused on Glaucoma and retinal disorders (9 papers), Retinal Development and Disorders (6 papers) and Nitric Oxide and Endothelin Effects (3 papers). Masaki Ichikawa collaborates with scholars based in Japan and United States. Masaki Ichikawa's co-authors include Sumio Watanabe, Yasuo Miyake, Masanori Kayano, Ikuo Kushida, Naoki Asakawa, Yasuo Miyake, Takeshi Miyakawa, Toshinobu Miwa, Yoshiko Iwasaki and Tomoyuki Okutsu and has published in prestigious journals such as Development, Brain Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Masaki Ichikawa

24 papers receiving 708 citations

Peers

Masaki Ichikawa
Hovhannes J. Gukasyan United States
Masaki Ichikawa
Citations per year, relative to Masaki Ichikawa Masaki Ichikawa (= 1×) peers Hovhannes J. Gukasyan

Countries citing papers authored by Masaki Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Masaki Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Ichikawa more than expected).

Fields of papers citing papers by Masaki Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Ichikawa. The network helps show where Masaki Ichikawa may publish in the future.

Co-authorship network of co-authors of Masaki Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Ichikawa. A scholar is included among the top collaborators of Masaki Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Ichikawa. Masaki Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nakajima, Atsushi, et al.. (2023). High-fiber liquid diet for chronic constipation: An exploration from healthcare providers' survey results. Clinical Nutrition Open Science. 52. 34–48. 1 indexed citations
2.
Fuwa, Masahiro, Carol B. Toris, Shan Fan, et al.. (2018). Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys. Journal of Ocular Pharmacology and Therapeutics. 34(7). 531–537. 66 indexed citations
3.
Taniguchi, Takazumi, Miki Takahashi, Ryo Iwamura, et al.. (2017). Omidenepag isopropyl, a selective EP2 agonist, shows additive intraocular pressure (IOP)-lowering effects when used concomitantly with existing anti-glaucoma drugs in animal models. Investigative Ophthalmology & Visual Science. 58(8). 2105–2105. 1 indexed citations
4.
Yoshizaki, Goro, Masaki Ichikawa, Makoto Hayashi, et al.. (2010). Sexual plasticity of ovarian germ cells in rainbow trout. Development. 137(9). 1584–1584. 3 indexed citations
5.
Hara, Hideaki, Masaki Ichikawa, Hidehiro Oku, Masamitsu Shimazawa, & Makoto Araie. (2005). Bunazosin, a Selective α1 ‐Adrenoceptor Antagonist, as an Anti‐glaucoma Drug: Effects on Ocular Circulation and Retinal Neuronal Damage. Cardiovascular Drug Reviews. 23(1). 43–56. 24 indexed citations
6.
Rao, Ponugoti Vasantha, Atsushi Shimazaki, Masaki Ichikawa, Jorge A. Alvarado, & David L. Epstein. (2005). Effects of Novel Ethacrynic Acid Derivatives on Human Trabecular Meshwork Cell Shape, Actin Cytoskeletal Organization, and Transcellular Fluid Flow. Biological and Pharmaceutical Bulletin. 28(12). 2189–2196. 10 indexed citations
7.
Ichikawa, Masaki, et al.. (2004). Effects of Topically Instilled Bunazosin, an α1-Adrenoceptor Antagonist, on Constrictions Induced by Phenylephrine and ET-1 in Rabbit Retinal Arteries. Investigative Ophthalmology & Visual Science. 45(11). 4041–4041. 21 indexed citations
8.
Okada, Yuji, Masaki Ichikawa, Kiyoshi Ishii, & Hideaki Hara. (2004). Effects of Topically Instilled Bunazosin Hydrochloride and Other Ocular Hypotensive Drugs on Endothelin-1-induced Constriction in Rabbit Retinal Arteries. Japanese Journal of Ophthalmology. 48(5). 465–469. 5 indexed citations
9.
Goto, Wakana, Masaki Ichikawa, Etsuko Tanaka, Hideaki Hara, & Makoto Araie. (2004). Bunazosin hydrochloride reduces glutamate-induced neurotoxicity in rat primary retinal cultures. Brain Research. 1003(1-2). 130–137. 5 indexed citations
10.
Shimazaki, Atsushi, et al.. (2004). Effects of the New Ethacrynic Acid Derivative SA9000 on Intraocular Pressure in Cats and Monkeys. Biological and Pharmaceutical Bulletin. 27(7). 1019–1024. 11 indexed citations
11.
Kaneko, Yumi, Masaki Ichikawa, Yasuo Kurimoto, Kouichi Ohta, & Nagahisa Yoshimura. (2003). Neuronal Differentiation of Hippocampus-Derived Neural Stem Cells Cultured in Conditioned Medium of Embryonic Rat Retina. Ophthalmic Research. 35(5). 268–275. 10 indexed citations
12.
Kushida, Ikuo, Masaki Ichikawa, & Naoki Asakawa. (2002). Improvement of Dissolution and Oral Absorption of ER-34122, A Poorly Water-Soluble Dual 5-Lipoxygenase/Cyclooxygenase Inhibitor With Anti-Inflammatory Activity by Preparing Solid Dispersion. Journal of Pharmaceutical Sciences. 91(1). 258–266. 59 indexed citations
13.
Kurimoto, Yasuo, Hiroto Shibuki, Yumi Kaneko, et al.. (2001). Transplantation of adult rat hippocampus-derived neural stem cells into retina injured by transient ischemia. Neuroscience Letters. 306(1-2). 57–60. 74 indexed citations
14.
Gotoh, Norimoto, et al.. (2001). Molecular cloning and characterization of human PTB-like protein: a possible retinal autoantigen of cancer-associated retinopathy. Journal of Neuroimmunology. 120(1-2). 161–169. 13 indexed citations
15.
Nakamuta, Hiromichi, et al.. (1997). Plasma level monitoring of nasal salmon calcitonin in the rat by a heterogeneous two-site enzyme immunoassay. Journal of Clinical Laboratory Analysis. 11(3). 129–131. 5 indexed citations
17.
Hoshino, Takashi, Hiromichi Nakamuta, Masaki Ichikawa, & Masao Koida. (1994). Influence of osteostatin on osteoclast morphology.. The Japanese Journal of Pharmacology. 64. 289–289. 1 indexed citations
18.
Ichikawa, Masaki, Takashi Kato, Masahiro Kawahara, Sumio Watanabe, & Masanori Kayano. (1991). A New Multiple-Unit Oral Floating Dosage System. II: In Vivo Evaluation of Floating and Sustained-Release Characteristics with p-Aminobenzoic Acid and Isosorbide Dinitrate as Model Drugs. Journal of Pharmaceutical Sciences. 80(12). 1153–1156. 40 indexed citations
19.
Ichikawa, Masaki, Sumio Watanabe, & Yasuo Miyake. (1991). A New Multiple-Unit Oral Floating Dosage System. I: Preparation and In Vitro Evaluation of Floating and Sustained-Release Characteristics. Journal of Pharmaceutical Sciences. 80(11). 1062–1066. 98 indexed citations
20.
Miwa, Toshinobu, et al.. (1987). Direct liquid chromatographic resolution of racemic compounds. Use of ovomucoid as a column ligand.. Chemical and Pharmaceutical Bulletin. 35(2). 682–686. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026